Você procurou por: there is insufficient data in patients (Inglês - Maltês)

there is insufficient information for use in paediatric patients.
m’ hemmx biżżejjed informazzjoni dwar l- użu fit- tfal.

there is limited data in patients with ps ≥2.
hemm dejta limitata f’pazjenti li għandhom ps ta’ ≥2.

there is limited data in patients with cardiac impairment.
hemm dejta limitata f’pazjenti b’indeboliment tal-qalb.

there is a lack of data in patients with renal impairment.
hemm nuqqas ta’ dejta f’pazjenti b’indeboliment tal-kliewi.

there is insufficient data in patients with impaired liver function (see section 4.3).
m’ hemmx tagħrif biżżejjed dwar pazjenti b’ indeboliment tal- funzjoni tal- fwied (ara sezzjoni 4. 3).

pharmacokinetic data in patients
dejta farmakokinetika f’pazjenti

there are insufficient data to justify the use in patients with prior nnrti failure.
ma hemmx tagħrif biżżejjed li jiġġustifika l-użu f’pazjenti b’falliment nnrti preċedenti.

there is insufficient data to determine the clinical significance.
m’hemm biżżejjed dejta sabiex tiddetermina s-sinifikanza klinika.

there are insufficient data to draw conclusions regarding exposure in patients > 70 years old.
m’hemmx dejta biżżejjed biex isiru konklużjonijiet fir-rigward tal-esponiment f’pazjenti ta’ > 70 sena.

there is insufficient data to further evaluate filgrastim use in paediatric subjects.
m’hemmx biżżejjed dejta biex jiġi vvalutat ulterjorment l-użu ta’ filgrastim f’individwi pedjatriċi.

there is insufficient data to determine the clinical significance of this effect in pregnancy.
m’hemmx dejta sufficjenti sabiex tiddetermina is-sinifikanza klinika ta’ dan l-effett fuq it-tqala.

there is insufficient data on the diagnostic liability of the helicobacter test infai to recommend its use in patients with gastrectomy.
qaghad m' hemmx biżżejjed informazzjoni rigward dispożizzjoni dijanjostika tal- helicobacter test infai sabiex din tiġi rakkomandata f’ pazjenti b’ gastrektomija u pazjenti li huma iżgħar minn 12- il sena fl- età.

patients with hepatic impairment there is no pharmacokinetic data in patients with hepatic impairment.
pazjenti b’ indeboliment fil- fwied mhemmx tagħrif farmakokinetiku f’ pazjenti b’ indeboliment fil- fwied.

there is limited data in patients between 75-84 years old (n=60).
hemm data limitata f’pazjenti li għandhom bejn 75-84 sena (n=60).

at present, there is insufficient data available on patients being retreated to recommend multiple treatment courses.
fil-preżent, m’hemmx data biżżejjed fuq pazjenti li qed ikunu jerġgħu ttrattati biex jistgħu jiġu rrakkomandati korsijiet ripetuti ta’ kura.

if cisplatin is discontinued, there are insufficient data regarding continuing monotherapy with topotecan in patients with cervical cancer.
jekk cisplatin jitwaqqaf, m’hemmx tagħrif biżżejjed dwar it-tkomplija ta’ topotecan bħala monoterapija f’pazjenti b’kanċer ċervikali.

there is insufficient data to evaluate filgrastim use in geriatric subjects for other approved filgrastim indications.
m’hemmx dejta biżżejjed biex jiġi evalwat l-użu ta’ filgrastim f’individwi ġerjatriċi għall- indikazzjonijiet oħra approvati ta’ filgrastim.

there are insufficient data to establish the safety and efficacy in patients ≥ 75 years due to limited data in this subgroup.
m’hemmx biżżejjed dejta biex jiġu stabbiliti s-sigurtà u l-effikaċja f’pazjenti ≥ 75 sena minħabba dejta limitata f’dan is-sottogrupp.

there is insufficient data among different races with posaconazole concentrate for solution for infusion.
m’hemmx dejta suffiċjenti bejn razez differenti bil-konċentrat għal soluzzjoni għall-infużjoni ta’ posaconazole.

there is insufficient data on the diagnostic reliability of the helicobacter test infai for children of the age 3-11 for recommending its use in patients with gastrectomy.
qaghad m’ hemmx biżżejjed informazzjoni fuq l- affidabilità dijanjostika ta ’ helicobacter test infai għal tfal bejn l- etajiet ta ’ 3 snin sa 11- il sena sabiex l- użu tiegħu jiġi wżat f' pazjenti b' gastrektomija.